Observational study reveals low immunonutritional status leads to poorer treatment transition in metastatic colorectal cancer, suggesting urgent need for assessment.
A poor immunonutritional status at the initiation of FTD/TPI + Bev therapy may lead to a lower rate of transitioning to subsequent treatments, thus resulting in a worse prognosis.
No takes yet. Share an insight, caveat, or question.
Seki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: